Russell Investments Group’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-323,100
Closed -$371K 3421
2022
Q4
$371K Sell
323,100
-727,100
-69% -$80.1M ﹤0.01% 2387
2022
Q3
$1.06M Hold
1,050,200
﹤0.01% 1902
2022
Q2
$1.06M Buy
+1,050,200
New +$115M ﹤0.01% 1935
2022
Q1
Sell
-1,275,500
Closed -$1.46M 2998
2021
Q4
$1.46M Buy
+1,275,500
New +$145M ﹤0.01% 1959
2021
Q1
Sell
-10,636
Closed -$1.16M 3222
2020
Q4
$1.16M Buy
+10,636
New +$1.15M ﹤0.01% 2056

Other funds holding BSX.PRA

Russell Investments Group's BSX.PRA Position: Q1 2023 in Review

Russell Investments Group sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q1 2023, closing a stake of 323,100 shares — an estimated $371K sold.

Russell Investments Group first reported a position in BSX.PRA in Q4 2020 and held it in 5 quarters. The position peaked at $1.46M in Q4 2021. 56 funds tracked by Wall St. Rank hold BSX.PRA as of Q1 2023.

  • Russell Investments Group reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q1 2023 after selling out during the quarter.
  • Russell Investments Group sold 323,100 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q1 2023, an estimated $371K.
  • Russell Investments Group first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2020 and held it in 5 quarters.
  • Russell Investments Group's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $1.46M in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q1 2023.

Based on Russell Investments Group's 13F filing for Q1 2023, filed 9 May 2023.